Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions

Sponsor
Artann Laboratories (Industry)
Overall Status
Completed
CT.gov ID
NCT02294383
Collaborator
National Institute on Aging (NIA) (NIH)
138
2
17
69
4.1

Study Details

Study Description

Brief Summary

The clinical study includes investigation of the outcomes of surgery for biomechanical restoration of pelvic floor conditions, monitoring pelvic floor conditions under conservative treatment/management, identification and investigation changes of pelvic floor muscle contractions and their significance in characterization of pelvic floor conditions, assessment of tactile imaging reproducibility, including pelvic floor muscle contraction.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    138 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions
    Study Start Date :
    Aug 1, 2014
    Actual Primary Completion Date :
    Jan 1, 2016
    Actual Study Completion Date :
    Jan 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Pre/post surgery pelvic floor assessment

    Conservative treatmen monitoring

    Pelvic floor muscle contrictions

    Imaging reproducibility

    Outcome Measures

    Primary Outcome Measures

    1. Tissue elasticity measured as a gradient in tactile image. Unit of Measure: kPa/mm [From 1 day to 12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • No prior pelvic floor surgery, and

    • Normal pelvic floor conditions, or

    • POP Stage I affecting one or more vaginal compartment, or

    • POP Stage II affecting one or more vaginal compartment, or

    • POP Stage III affecting one or more vaginal compartment, or

    • POP Stage IV affecting one or more vaginal compartment.

    Exclusion Criteria:
    • Active skin infection or ulceration within the vagina

    • Presence of a vaginal septum;

    • Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;

    • Ongoing radiation therapy for pelvic cancer;

    • Impacted stool;

    • Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvadynia;

    • Severe hemorrhoids;

    • Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician;

    • Current pregnancy.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Princeton Urogynecology Princeton New Jersey United States 08540
    2 Institute of Female Pelvic Medicine and Reconstructive Surgery Allentown Pennsylvania United States 18103

    Sponsors and Collaborators

    • Artann Laboratories
    • National Institute on Aging (NIA)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Artann Laboratories
    ClinicalTrials.gov Identifier:
    NCT02294383
    Other Study ID Numbers:
    • VTI05
    • R44AG034714
    First Posted:
    Nov 19, 2014
    Last Update Posted:
    Jun 7, 2018
    Last Verified:
    Jun 1, 2018
    Keywords provided by Artann Laboratories
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 7, 2018